| Both sides previous revision
Previous revision
Next revision
|
Previous revision
|
md_biochemistry [2026/02/17 11:57] admin |
md_biochemistry [2026/06/26 13:25] (current) admin |
| | [[Induction for Newly Join Resident Doctor]] |
| | |
| =====Seminar and Micro- Teaching For MD Biochemistry===== | =====Seminar and Micro- Teaching For MD Biochemistry===== |
| |
| |31|:::| | | |31|:::| | |
| |24|<html><span style="font-size:150%;">Dr Janki Sonagra</span></html> |Ammonia Detoxification|{{ ::ammonia_detoxification_2_2_.pptx |}}| | |24|<html><span style="font-size:150%;">Dr Janki Sonagra</span></html> |Ammonia Detoxification|{{ ::ammonia_detoxification_2_2_.pptx |}}| |
| |25|:::|Prion Disease |[[https://docs.google.com/presentation/d/15jx6CwLXlqoAOEvX0uWkMF1tEPY38PIv/edit?usp=drive_link&ouid=105726813387160537689&rtpof=true&sd=true|Prion Disease]] | | |25|:::|Prion Disease |{{ ::prion_disease.pptx.pdf |}}| |
| |26|:::| | | |26|:::|Tertery & Quaternary Protein structure |{{ :protein_structure_1_1_.pptx.pdf |}}| |
| |27|:::| | | |27|:::|Arginine Metabolism|{{ ::arginine_metabolism_2_.pptx.pdf |}}| |
| |28|:::| | | |28|:::|Hartnup disease|{{ ::hartnup_s_disease_-_new.pptx.pdf |}}| |
| |29|:::| | | |29|:::|IQC|{{ ::iqc_janki.ppt.pdf |}}| |
| |30|:::| | | |30|:::| | |
| |31|:::| | | |31|<html><span style="font-size:150%;">Dr Nishit Chudasama</span></html> | | |
| | |31|<html><span style="font-size:150%;">Dr Shivam</span></html> | | |
| |
| =====Model Questions List For MD Biochemistry===== | =====Model Questions List For MD Biochemistry===== |
| - Technical requirement to maintain integrity of the sample between sample collection to analysis as per clause 7.2.5 and 7.2.7.3 of ISO 15189:2022 and expected risk on sample stability for biochemistry analytes. | - Technical requirement to maintain integrity of the sample between sample collection to analysis as per clause 7.2.5 and 7.2.7.3 of ISO 15189:2022 and expected risk on sample stability for biochemistry analytes. |
| - Write two enzyme with it’s therapeutic use with it’s mechanism of action. | - Write two enzyme with it’s therapeutic use with it’s mechanism of action. |
| | - ''Define HIL indexation and it’s significant in clinical biochemistry laboratory'' |
| | - ''Metabolic and endocrine changes during fasting condition and during exercise'' |
| | - ''Fact and Myth of the use of olive oil in food preparation.'' |
| | - ''Biochemical impact of different food additive and adulteration.'' |
| | - ''Structure and Function of Gluten , especially as food protein.'' |
| | - ''Molar absorptivity of NADh and calculation of enzyme factors'' |
| | - ''Biochemical explanation of pulmonary embolism in deep sea divers'' |
| | - ''Requirement as per ISO 15189:2022 for POCT.'' |
| | |
| | |
| | |
| |
| |
| - Biochemical basis of etiology, diagnosis and treatment of unconjugated neonatal hyperbilirubinemia. | - Biochemical basis of etiology, diagnosis and treatment of unconjugated neonatal hyperbilirubinemia. |
| - Amphibolic role of TCA cycle. | - Amphibolic role of TCA cycle. |
| - Metabolic changes during exercise. | - Metabolic changes during exercise. |
| - Biochemistry basis of change in enzyme activity due to change in pH and temperature. | - Biochemistry basis of change in enzyme activity due to change in pH and temperature. |
| - Biochemical explanation of galactosemia | - Biochemical explanation of galactosemia |
| - ATP IV Hypercholesterolemia diagnostic guidline | - ATP IV Hypercholesterolemia diagnostic guidline |
| - beta thalassemia – genetics, pathogenesis, diagnosis | - beta thalassemia – genetics, pathogenesis, diagnosis |
| | - ''Define tertiary structure of protein with domain and chaperon. Explain pathogenesis of prion disease with example of amyloidosis.'' |
| | - ''Enumerate cholesterol synthesis with regulation. Describe type of dyslipidemia. Explain framingham risk scores for cardiovascular risk.'' |
| | - ''Metabolic and neuro-transmitter alteration during alcohol addiction and withdrawal.'' |
| | - ''Classify obesity. Explain endocrinal pathogenesis of obesity.'' |
| | - ''Function and significant of PTH and Intact PTH.'' |
| | - ''Effect of cirrhosis of liver on metabolism and digestion – absorption'' |
| | - ''Genetic regulation of haemoglobin synthesis and impact of therapeutic drugs & metal on it.'' |
| | - ''Explain “Role of vitamins on metabolism” (with examples)'' |
| | - ''Alteration in blood buffer and renal buffer in case of extensive interstitial lung disease.'' |
| | |
| | |
| | |
| | |
| |
| |<html> <span style="color: #700800 ;font-size:125%;">2024</span> </html>|<html> <span style="color: #700800 ;font-size:125%;">List of Model Question for Paper-3 - Molecular Biology , Immunology and Cancer</span> </html>| | |<html> <span style="color: #700800 ;font-size:125%;">2024</span> </html>|<html> <span style="color: #700800 ;font-size:125%;">List of Model Question for Paper-3 - Molecular Biology , Immunology and Cancer</span> </html>| |
| - Write note somatic hyper mutation and iso-type switching of immunoglobin. | - Write note somatic hyper mutation and iso-type switching of immunoglobin. |
| - Regulation of m-RNA stability | - Regulation of m-RNA stability |
| | - ''Type and significance of all the type of RNA. Clinical co-relation of RNA in pathogenesis of cancer , atherosclerosis and Age related Macular Degeneration (AMD)'' |
| | - ''Viral integration and transposons in human genome. Molecular impact of anti-viral drugs - Acylovir.'' |
| | - ''Regulation of eukaryotic gene expression'' |
| | - ''Journey of human genome evolution from mutation to substitution.'' |
| | - ''Tumor Supressor Gene - BRCA and p53'' |
| | - ''Meiosis vs Mitosis'' |
| | - ''Molecular defect in cystic fibrosis'' |
| | - ''Quantitative Real time PCR'' |
| | - ''DNA dependent DNA polymerase and DNA ligase.'' |
| | |
| | |
| | |
| | |
| |
| |<html> <span style="color: #700800 ;font-size:125%;">2024</span> </html>|<html> <span style="color: #700800 ;font-size:125%;">List of Model Question for Paper-4 - Technique in experimental biochemistry , Recent advances</span> </html>| | |<html> <span style="color: #700800 ;font-size:125%;">2024</span> </html>|<html> <span style="color: #700800 ;font-size:125%;">List of Model Question for Paper-4 - Technique in experimental biochemistry , Recent advances</span> </html>| |
| - Write performance validation protocol for these specified resource ( instrument / reagent / consumable) | - Write performance validation protocol for these specified resource ( instrument / reagent / consumable) |
| - Write a consistent quality policy and objective with defined quality indicator, for your laboratory. | - Write a consistent quality policy and objective with defined quality indicator, for your laboratory. |
| | - ''Enumerate analytical methods with it’s principle , significant and limitation of creatinine estimation and eGFR.'' |
| | - ''Definition of quality indicator with it’s standard requirements. Define quality indicator for period of sample collection to sample receipt (minimum four QI ) and sample storage (minimum four QI ) with process of it’s monitoring and measuring elements.'' |
| | - ''Principle and utility of Fourier Transform Infrared (FTIR) spectroscopy in clinical biochemistry laboratory. Approach to validate the result of FTIR.'' |
| | - ''Structure and component of “Foundation Course” for First year Indian Medical Graduate (IMG)'' |
| | - ''AETCOM'' |
| | - ''Document Control and Control of Record as per ISO 15189:2022'' |
| | - ''Use of moving average of patient data as IQC alternative'' |
| | - ''Delta Bilirubin - Define and Clinical significant.'' |
| | - ''Component and Principle of Flame Photometer'' |
| | - ''Mechanism , clinical utility and biochemical adverse event with use of GLP-1 analogues'' |
| | - ''Sample acceptance exception in case of wrong vacuette (Write minimum 4 scenario)'' |
| | |
| | |
| | |
| | |
| |
| |<html> <span style="color: #700800 ;font-size:125%;">2024</span> </html>|<html> <span style="color: #700800 ;font-size:125%;">Drugs To Read With Biochemical Mechanism</span> </html>| | |<html> <span style="color: #700800 ;font-size:125%;">2024</span> </html>|<html> <span style="color: #700800 ;font-size:125%;">Drugs To Read With Biochemical Mechanism</span> </html>| |
| - Tocilizumab | - Tocilizumab |
| - Hydroxychloroquine | - Hydroxychloroquine |
| | - Rifaximin |